Christopher Austin’s Post

Dr. Dennis Liotta's passion for drug discovery really shines through in this podcast. Check out the full interview at the link below: https://lnkd.in/eMNCscK4. Dennis Liotta

New blog post! Read how Ambit elevated traditional rep triggers programs by offering the ability to supplement field efforts with email and NPI targeted media campaigns. Transparent models...continuous optimization...quantifiable results...that's the Ambit way!

Check out a summary of the #SingleDrugAssessments in #LungCancer assessed in the last 12 years. Want a more detailed analysis? Request a free trial! https://lnkd.in/dAUP6PVc #marketaccess

In the fast-paced world of biopharma, finding the right patients is crucial—especially when it comes to rare diseases. Traditional claims data analysis has its limitations, but Ambit's Dynamic LeadGen is here to change the game. Dynamic LeadGen is designed to explicitly address rare disease patient finding challenges, setting a new standard in the market, combining transparency, measurable impact, continuous optimization, proactive adaptation, and a client-centric philosophy. Discover how we're reimagining rare disease patient finding and paving the way for a healthier, more equitable future—read our new blog post now: https://hubs.li/Q02xNn1q0 #dynamicleadgen #patientfinding #patientidentification #claimsdata #claimsdatanalysis #ontheblog #blog

Exciting Medical Innovation Update! Here at IDM Insight we are delighted to share the first release from our series “Insight: Accelerating your Drug Discovery & Development” A series focused on our innovative Pharma intelligence platform “Insight” which will provide an extensive breakdown of our platform and how it will transform the way you approach drug discovery, research and development. Our first article, "Not Just Your Average Disease Database” unveils a game-changing solution for researchers, clinicians, and pharmaceutical pros alike. Dive into the technical details of our comprehensive disease database, revolutionizing the way we organize information, identify pathways, and discover drugs. In Pharmacology, get a comprehensive overview of molecular processes to pinpoint potential drug targets and understand pathways. We go beyond data – providing actionable insights for your research pipelines! But wait, there's more! Our database isn't just data; it's the future. Coupled with AI, it's a powerhouse interpreting vast datasets, identifying patterns, and accelerating discovery. Ready to reshape your medical research? Click the image below to explore the full article and unlock the potential for innovation in your research pipelines. #IDMInsight #MedicalInnovation #DrugDiscovery #AIinMedicine

Designing a #RareDisease #ClinicalTrial first requires a deep understanding of the unique challenges in this space—like a limited understanding of the disease and that few diagnostic tools are available. In this video, learn about the new approaches we continue to pioneer to accelerate the discovery and development of transformative medicines.

After relapsing on the only drug in development for my rare disease, my doctors told me ‘We’ve tried everything, there’s nothing more that we can do.’ To make things worse, I didn’t have a billion dollars and 10 years to develop a new drug from scratch. My only hope was to find a drug that was already FDA-approved that I could repurpose for my disease. It’s been over 9.5 years that I’ve been in remission and we have been able to identify and advance numerous treatments for diseases they weren’t initially intended for. Now through Every Cure we are utilizing artificial intelligence to maximize the potential of all existing drugs to treat every disease they possibly can. What rare disease would you like to find a repurposed drug to treat? #raredisease #drugdevelopment #drugdelivery #medicine

ASTRAZENEKA's ALPHA Study met all key secondary endpoints at 12 weeks and demonstrated sustained efficacy through 48 weeks. Check out all key secondary data effortlessly at our Efortless Update. Follow this link to read more➡️: https://lnkd.in/gvsienwU

// Patient associations/Industry: the key to a positive interaction // What rare disease patients and families want is a simpler life. Discover what makes the relationship between members of a patients’ association and a biotech company work so well in this interview! #kayentis #eCOA #clinicaltrials #raredisease #patientassociation

Horizontal thinking saved my life… I didn't have $1 billion or ten years to develop a new drug from scratch. My survival hinged on one critical strategy: identifying and repurposing an existing drug made for another disease to treat my own. This approach isn't just a personal story; it's a powerful example of 'horizontal thinking'—a concept many of us apply without even realizing it. Horizontal thinking is about looking across the spectrum of problems and solutions, rather than tunneling vertically into a single area. It's about exploring what already exists in parallel fields or industries to solve the problems we face. Drug repurposing is a perfect example of this and is why we are so passionate about our mission at Every Cure. How has thinking 'horizontally' helped you solve problems in unexpected ways?